Leonard L. Mazur is Chairman at Citius Pharmaceuticals, Inc. (CTXR). They have made 9 open-market trades across 2 companies since 2016, most recently 2025-09-19.
CIK 0001463414
9 open-market purchases totalling $21.5M since 2016, never a sale. Across 9 scored buys the stock is up 2.4% at ninety days, and 0.1 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 22% | 33% |
| Avg Move | -3.2% | -13.3% | +2.4% |
| Alpha | -5.8% | -14.0% | +0.1% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HILS | BUY | 2022-01-14 | 2022-01-18 | $4.00 | $100K | +44.0% | -25.9% | -48.5% |
| CTXR | BUY | 2019-09-27 | 2019-09-27 | $0.90 | $2.0M | -23.8% | -31.3% | +43.8% |
| CTXR | BUY | 2019-04-03 | 2019-04-05 | $1.55 | $3.6M | -15.6% | -19.3% | -25.9% |
| CTXR | BUY | 2018-08-13 | 2018-08-15 | $1.28 | $8.0M | -18.4% | -21.8% | -23.5% |
| CTXR | BUY | 2018-03-29 | 2018-04-02 | $2.99 | $1.0M | -6.1% | -21.0% | -23.9% |
| CTXR | BUY | 2017-12-19 | 2018-01-08 | $4.69 | $2.0M | +8.5% | -1.0% | -24.5% |
| CTXR | BUY | 2017-08-24 | 2017-08-28 | $2.68 | $29K | +8.7% | +5.0% | +62.2% |
| CTXR | BUY | 2017-08-08 | 2017-08-10 | $4.13 | $1.7M | -8.0% | +4.3% | +70.6% |
| CTXR | BUY | 2016-03-30 | 2016-04-12 | $0.60 | $3.0M | -18.2% | -8.8% | -8.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.